MedPath

Homeopathic treatment of common cold in childre

Phase 3
Conditions
Health Condition 1: J069- Acute upper respiratory infection,unspecified
Registration Number
CTRI/2023/07/055490
Lead Sponsor
ehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Children of age group 3-11 years

2. Patients of either sex

2. Clinical signs and symptoms of an URTI with a duration of 24 hours or more with or without fever >=37.5áµ?C

3. At least 1 of 3 types of URTI symptoms â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease)

4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active.

5. Literate guardians or attendants capable of understanding and filling the WURSS-21, CARIFS and URI-SSS questionnaires in local vernaculars, i.e., Bengali, Hindi and/or English.

Exclusion Criteria

1. Severe or complicated course of URTI â?? bronchitis, pneumonia, sinusitis, otitis media, coinfection with bacterial agents, and exacerbation of pre-existing medical conditions, particularly asthma and chronic obstructive pulmonary disease, meningitis and sepsis

2. Signs of acute LRTI

3. COVID-19 positive cases as diagnosed by rapid antigen kit or RT-PCR method

4. Current symptoms mainly induced by other acute ENT diseases

5. Daily use of antibiotics, steroids and cytotoxic agents

6. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects

7. Diagnosed cases of uncontrolled or life-threatening illness affecting quality of life or any organ failure

8. Self-reported immune-compromised state (e.g., HIV)

9. Undergoing homeopathic treatment for any chronic disease(s) within last 6 months

10. Simultaneous participation in any other clinical trials

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time (measured in days) to complete clinical recovery between groupsTimepoint: Baseline, 4 (±1) days, 8 (±1) days & 15 (±2) days
Secondary Outcome Measures
NameTimeMethod
Canadian Acute Respiratory Illness & Flu Scale (CARIFS) scoresTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days;URI Symptom Severity Scale (URI-SSS) scoresTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days;Wisconsin Upper Respiratory Symptom Survey (WURSS-21) scoreTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days
© Copyright 2025. All Rights Reserved by MedPath